psammomatous melanotic schwannoma complex

psammomatous melanotic schwannoma complex Frontiers | Case Report: Anlotinib

Name: psammomatous melanotic schwannoma complex Frontiers | Case Report: Anlotinib
Brand: astonvaughan.co.uk
SKU: 35971626254
Price: 23.35 USD
Availability: InStock
Rating: 4.4743 (5 reviews)

Frontiers Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor Intracranial Melanotic Schwannomas: Rare and Distinctive Tumors to Know Due to their Risk of Recurrence and Metastases Journal of the Belgian Society of Radiology Psammomatous melanotic schwannoma presenting as colonic polyps Virchows Archiv Springer Nature Link Intrathoracic Psammomatous Melanotic Schwannoma Associated With the Carney Complex ScienceDirect

SKU: 35971626254 · From astonvaughan.co.uk

4.5

USD23.35 USD54.35

Pay in 4 interest-free payments of $5.84 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

A novel cysteine-rich domain of Sep15 mediates the interaction with UDP-glucose:glycoprotein glucosyltransferase

this enzyme is essential for the regulation of ferroptosis because it decreases glutathione and increases cellular ROS levels ( Prostaglandin-endoperoxide synthase 2 (PTGS2) encodes the enzyme cyclooxygenase 2, which catalyzes lipid oxidation ( Arachidonic acid 12 lipoxygenase (ALOX12) is also closely associated with p53-mediated ferroptosis ( TP53-induced glycolysis and apoptosis regulator (TIGAR) is a target gene of p53 that inhibits cancer and has an antioxidant effect ( p53 can also promote ferroptosis by influencing the function of ferredoxin reductase (FDXR) in iron metabolism ( 2.2 Negative Regulation of Ferroptosis by p53 In addition to its ferroptosis-promoting effects, p53 represses ferroptosis by inducing cyclin-dependent kinase inhibitor (CDKN1A, encoding p21), Parkinson disease 2 (PARK2) and iPLA2, or by inhibiting dipeptidyl peptidase-4 (DPP4) (Figure 2)